There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could ...

SAN ANTONIO, Texas--(BUSINESS WIRE)--A new economic study found that adding CyPath® Lung, bioAffinity Technologies’ noninvasive test for detection of early-stage lung cancer, to the standard of care ...

For most patients, the diagnosis and surgical treatment of an early-stage cancerous lung tumor is a drawn-out process. “At about 99 percent of the hospitals in the country, they come in for a ...

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced that WPS Government Health Administrators, ...

Lung tumoroids as a testing platform for precision CAR T-cell therapy. Nature Biomedical Engineering (2025). DOI: 10.1038/s41551-025-01594-3 ...

Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the publication of a new prospective clinical trial in Transplantation Direct . The study, which was conducted by ...

Previous studies by Oregon Health & Science University researchers have shown that taking vitamin C during pregnancy may help reduce some of the damage to infant health caused by smoking. A new study ...

Biodesix, Inc. announced a new study published in CHEST Pulmonary Journal reaffirming the effectiveness of its Nodify CDT® blood-based lung nodule test, which assesses seven autoantibodies linked to ...